Frontiers in Cardiovascular Medicine (Sep 2024)
Editorial: Methods in cardiovascular biologics and regenerative medicine
- Narasimman Gurusamy,
- Olaf Bergmann,
- Olaf Bergmann,
- Olaf Bergmann,
- Clotilde Castaldo,
- Ngan F. Huang,
- Ngan F. Huang,
- Ching-Ling Lien,
- Jun Jie Tan,
- Felix B. Engel
Affiliations
- Narasimman Gurusamy
- Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States
- Olaf Bergmann
- Department of Pharmacology and Toxicology, University Medical Center Goettingen, Goettingen, Germany
- Olaf Bergmann
- Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden
- Olaf Bergmann
- DZHK (German Centre for Cardiovascular Research), Partner Site Lower Saxony, Lower Saxony, Germany
- Clotilde Castaldo
- Department of Public Health, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy
- Ngan F. Huang
- Department of Cardiothoracic Surgery, Stanford University, Palo Alto, CA, United States
- Ngan F. Huang
- Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto, Health Care System, Palo Alto, CA, United States
- Ching-Ling Lien
- Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States
- Jun Jie Tan
- USM-ALPS Laboratory for Heart Research, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia
- Felix B. Engel
- 0Department of Nephropathology, Institute of Pathology and Department of Cardiology, Experimental Renal and Cardiovascular Research, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
- DOI
- https://doi.org/10.3389/fcvm.2024.1477927
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
- methods in cardiovascular biologics
- regenerative medicine
- tissue engineering
- pericytes
- cardiac remuscularization
- 3D-bioprinting